Welch Group, LLC Alaunos Therapeutics, Inc. Transaction History

Welch Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	SELL	$0.5 - $261.0 $7,850 - $4.1 Million	-15,700 Reduced 26.75%	43,000 $27,000
Q3 2022 Oct 13, 2022	BUY	$1.04 - $322.5 $5,980 - $1.85 Million	5,750 Added 10.86%	58,700 $101,000
Q2 2022 Jul 21, 2022	BUY	$0.41 - $1.24 $2,029 - $6,138	4,950 Added 10.31%	52,950 $66,000
Q1 2020 Apr 28, 2020	BUY	$1.9 - $4.98 $91,200 - $239,040	48,000 New	48,000 $118,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Welch Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Welch Group, LLC with notifications on news.